2014 Q2 Form 10-Q Financial Statement

#000119312514295796 Filed on August 05, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $633.2M $557.3M
YoY Change 13.63% 2.71%
Cost Of Revenue $549.5M $483.4M
YoY Change 13.68% 2.63%
Gross Profit $83.77M $73.92M
YoY Change 13.33% 3.28%
Gross Profit Margin 13.23% 13.26%
Selling, General & Admin $64.56M $58.53M
YoY Change 10.3% 2.86%
% of Gross Profit 77.08% 79.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.800M $1.700M
YoY Change 5.88% 6.25%
% of Gross Profit 2.15% 2.3%
Operating Expenses $64.56M $58.53M
YoY Change 10.3% 2.86%
Operating Profit $19.20M $15.38M
YoY Change 24.83% 4.87%
Interest Expense $26.00K $46.00K
YoY Change -43.48% -28.13%
% of Operating Profit 0.14% 0.3%
Other Income/Expense, Net -$26.00K -$46.00K
YoY Change -43.48% 58.62%
Pretax Income $19.18M $15.34M
YoY Change 25.03% 5.23%
Income Tax $7.747M $6.183M
% Of Pretax Income 40.4% 40.31%
Net Earnings $11.43M $9.154M
YoY Change 24.85% 3.72%
Net Earnings / Revenue 1.8% 1.64%
Basic Earnings Per Share $0.44 $0.35
Diluted Earnings Per Share $0.43 $0.35
COMMON SHARES
Basic Shares Outstanding 26.21M shares 26.13M shares
Diluted Shares Outstanding 26.49M shares 26.38M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.30M $64.20M
YoY Change -6.07% 1.26%
Cash & Equivalents $60.29M $64.22M
Short-Term Investments
Other Short-Term Assets $10.90M $9.900M
YoY Change 10.1% 22.22%
Inventory $97.19M $77.14M
Prepaid Expenses
Receivables $295.3M $256.1M
Other Receivables
Total Short-Term Assets $464.5M $407.8M
YoY Change 13.91% 1.28%
LONG-TERM ASSETS
Property, Plant & Equipment $27.68M $27.37M
YoY Change 1.13% 9.91%
Goodwill $51.28M $51.28M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $698.0K $701.0K
YoY Change -0.43% -0.99%
Total Long-Term Assets $82.06M $82.65M
YoY Change -0.72% 1.31%
TOTAL ASSETS
Total Short-Term Assets $464.5M $407.8M
Total Long-Term Assets $82.06M $82.65M
Total Assets $546.6M $490.4M
YoY Change 11.45% 1.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $153.2M $124.6M
YoY Change 22.96% -9.83%
Accrued Expenses $35.30M $43.00M
YoY Change -17.91% -2.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $500.0K
YoY Change -50.0%
Total Short-Term Liabilities $188.5M $168.1M
YoY Change 12.15% -8.19%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $2.504M $2.968M
YoY Change -15.63% -1.62%
Total Long-Term Liabilities $2.504M $2.968M
YoY Change -15.63% -1.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $188.5M $168.1M
Total Long-Term Liabilities $2.504M $2.968M
Total Liabilities $207.3M $181.5M
YoY Change 14.24% -7.63%
SHAREHOLDERS EQUITY
Retained Earnings $249.0M $220.5M
YoY Change 12.93% 12.18%
Common Stock $106.1M $104.4M
YoY Change 1.6% 3.38%
Preferred Stock
YoY Change
Treasury Stock (at cost) $15.86M $15.98M
YoY Change -0.74% 62.64%
Treasury Stock Shares
Shareholders Equity $339.3M $308.9M
YoY Change
Total Liabilities & Shareholders Equity $546.6M $490.4M
YoY Change 11.45% 1.29%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $11.43M $9.154M
YoY Change 24.85% 3.72%
Depreciation, Depletion And Amortization $1.800M $1.700M
YoY Change 5.88% 6.25%
Cash From Operating Activities -$3.000M $8.000M
YoY Change -137.5% -52.38%
INVESTING ACTIVITIES
Capital Expenditures -$2.000M -$2.600M
YoY Change -23.08% 8.33%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.000M -$2.600M
YoY Change -23.08% 8.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 400.0K 300.0K
YoY Change 33.33% -137.5%
NET CHANGE
Cash From Operating Activities -3.000M 8.000M
Cash From Investing Activities -2.000M -2.600M
Cash From Financing Activities 400.0K 300.0K
Net Change In Cash -4.600M 5.700M
YoY Change -180.7% -58.09%
FREE CASH FLOW
Cash From Operating Activities -$3.000M $8.000M
Capital Expenditures -$2.000M -$2.600M
Free Cash Flow -$1.000M $10.60M
YoY Change -109.43% -44.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
783000
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
295327000
CY2014Q2 us-gaap Inventory Net
InventoryNet
97187000
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6382000
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26224138 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64219000
CY2014Q2 us-gaap Ratio Of Indebtedness To Net Capital1
RatioOfIndebtednessToNetCapital1
2.0 pure
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
188522000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15139000
CY2014Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
20161000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
153222000
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2504000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
339251000
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
105794000
CY2014Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
50000000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
249038000
CY2014Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
80000000
CY2014Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
50000000
CY2014Q2 us-gaap Liabilities
Liabilities
207307000
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
281000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
546558000
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
16281000
CY2014Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
0
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
698000
CY2014Q2 us-gaap Goodwill
Goodwill
51276000
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
15862000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27679000
CY2014Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2404000
CY2014Q2 us-gaap Assets
Assets
546558000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60289000
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4533000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14935000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
319829000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
104932000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
464501000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39907000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
162118000
CY2013Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
22362000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
124821000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2773000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
230478000
CY2013Q4 us-gaap Liabilities
Liabilities
181115000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
281000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
500944000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
16224000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
720000
CY2013Q4 us-gaap Goodwill
Goodwill
51276000
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2256000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
283051000
CY2013Q4 us-gaap Inventory Net
InventoryNet
79141000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6382000
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15862000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27600000
CY2013Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2854000
CY2013Q4 us-gaap Assets
Assets
500944000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42547000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5117000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
418494000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26329000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
26975000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
266000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26063000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
1062710000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4257000
us-gaap Income Taxes Paid
IncomeTaxesPaid
10936000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
151000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
228000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25412000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10613000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
660000
us-gaap Gross Profit
GrossProfit
140754000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-13000
us-gaap Operating Income Loss
OperatingIncomeLoss
25508000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-96000
us-gaap Net Income Loss
NetIncomeLoss
15252000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
527000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7498000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
307000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1594000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-110000
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
196000
us-gaap Share Based Compensation
ShareBasedCompensation
301000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
564000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3337000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
24312000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4257000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
115246000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10160000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1400000
us-gaap Cost Of Revenue
CostOfRevenue
921956000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1586000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
228000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6590000
dei Trading Symbol
TradingSymbol
PCCC
dei Entity Registrant Name
EntityRegistrantName
PC CONNECTION INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001050377
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2017-02-24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26485000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
20849000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
281000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
One-month LIBOR
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26204000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
us-gaap Sales Revenue Net
SalesRevenueNet
1193004000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3493000
us-gaap Income Taxes Paid
IncomeTaxesPaid
10933000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
343000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
34000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
34000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12641000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
30912000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2057000
us-gaap Gross Profit
GrossProfit
156613000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-22000
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
281000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
30948000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-36000
us-gaap Net Income Loss
NetIncomeLoss
18560000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18046000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
360000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
376000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
57000
us-gaap Share Based Compensation
ShareBasedCompensation
486000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
365000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3863000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
17742000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3483000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
125665000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12352000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28392000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000
us-gaap Cost Of Revenue
CostOfRevenue
1036391000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
34000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2232000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26379000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
252000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26127000 shares
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
557287000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15337000
CY2013Q2 us-gaap Gross Profit
GrossProfit
73916000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15383000
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
9154000
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1710000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58533000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6183000
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
483371000
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26487000 shares
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
120000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26206000 shares
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
633244000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19176000
CY2014Q2 us-gaap Gross Profit
GrossProfit
83766000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
19202000
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
11429000
CY2014Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1786000
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64564000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7747000
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
549478000

Files In Submission

Name View Source Status
0001193125-14-295796-index-headers.html Edgar Link pending
0001193125-14-295796-index.html Edgar Link pending
0001193125-14-295796.txt Edgar Link pending
0001193125-14-295796-xbrl.zip Edgar Link pending
d751840d10q.htm Edgar Link pending
d751840dex311.htm Edgar Link pending
d751840dex312.htm Edgar Link pending
d751840dex321.htm Edgar Link pending
d751840dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
pccc-20140630.xml Edgar Link completed
pccc-20140630.xsd Edgar Link pending
pccc-20140630_cal.xml Edgar Link unprocessable
pccc-20140630_def.xml Edgar Link unprocessable
pccc-20140630_lab.xml Edgar Link unprocessable
pccc-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending